Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Some statistical issues in modelling pharmacokinetic data.

J K Lindsey1, B Jones, P Jarvis

  • 1Biostatistics, Limburgs University, Belgium.

Statistics in Medicine
|August 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of an antiperspirant with emollients on foot-sweat accumulation and blister formation while walking in the heat.

Journal of the American Academy of Dermatology·1995
Same author

The achievement of isoeffective bronchial mucosal dose during endobronchial brachytherapy.

International journal of radiation oncology, biology, physics·1995
Same author

Entry of microbes into the host: using M cells to break the mucosal barrier.

Current opinion in immunology·1995
Same author

Derivation of the optimum dose per fraction from the linear quadratic model.

The British journal of radiology·1995
Same author

On the nature of the mutation in the nude rat.

Trends in genetics : TIG·1995
Same author

Radiotherapy and chemotherapy for inoperable non-small cell lung cancer.

Postgraduate medical journal·1995
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
Same journal

Subgroup Analysis of Interval-censored Failure Time Data With Application to Alzheimer's Disease.

Statistics in medicine·2026
Same journal

Rejoinder to Commentaries on "A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events".

Statistics in medicine·2026
Same journal

A Multi-Stage Drop-the-Loser Design With Superiority Boundaries.

Statistics in medicine·2026
Same journal

Interpretable ROI Identification in Brain Image Analysis: Overcoming CNN Black Box Challenges With Kriging-Enhanced Adaptive Sampling.

Statistics in medicine·2026
See all related articles

Population pharmacokinetic modeling benefits from random effects and autoregressive processes for better individual tracking and prediction. Statistical distribution assumptions, like log-normal, may not fit all data; gamma or log Cauchy distributions can offer more robust pharmacokinetic analysis.

Area of Science:

  • Pharmacokinetics
  • Statistical Modeling
  • Pharmacometrics

Background:

  • Pharmacokinetic (PK) compartment modeling traditionally assumes individual variability.
  • Population PK modeling uses random effects to balance individual differences with population inference.
  • Current methods may not fully capture complex PK data patterns.

Purpose of the Study:

  • To recommend advanced statistical modeling techniques for population pharmacokinetics.
  • To address limitations in current PK data analysis assumptions.
  • To improve the accuracy and robustness of pharmacokinetic modeling.

Main Methods:

  • Utilizing random effects models in data-rich pharmacokinetic studies.
  • Incorporating autoregressive processes alongside random effects for enhanced individual tracking.

Related Experiment Videos

  • Evaluating alternative statistical distributions (e.g., gamma, log Cauchy) beyond log-normal for PK data.
  • Addressing issues with variance dependence on the mean and handling non-detectable values as censored data.

    • Main Results:

    • Random effects models are recommended for data-rich PK studies, often needing augmentation with autoregressive processes.
    • The log-normal distribution is frequently unsuitable for PK data; gamma and log Cauchy distributions offer better fits, especially with extreme values.
    • Accounting for mean-variance dependence and proper handling of non-detectable data are crucial for accurate modeling.

    Conclusions:

    • Advanced statistical approaches, including autoregressive processes and flexible distribution choices, are vital for robust population pharmacokinetic modeling.
    • Standard assumptions in PK modeling may require revision to accommodate real-world data complexities.
    • Development of commercial software with more adaptable PK modeling tools is needed.